UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
August 19, 2004
GILEAD SCIENCES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE |
| 0-19731 |
| 94-3047598 |
(State or other jurisdiction of |
| (Commission File Number) |
| (I.R.S. Employer |
|
|
|
|
|
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA | ||||
(Address of principal executive offices) | ||||
| ||||
94404 | ||||
(Zip Code) | ||||
| ||||
(650) 574-3000 | ||||
(Registrant’s telephone number, including area code) | ||||
ITEM 5. OTHER EVENTS
On August 17, 2004, Gilead Sciences, Inc., a Delaware corporation, issued a press release announcing the establishment of a stock trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 by James M. Denny, Gilead’s non-executive Chairman of the Board. A copy of the press release is filed as Exhibit 99.1 to this report.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
Exhibit |
| Description |
99.1 |
| Press Release, issued by Gilead Sciences, Inc. on August 17, 2004 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GILEAD SCIENCES, INC. |
| (registrant) |
|
|
|
|
| /s/ John F. Milligan |
| John F. Milligan |
| Executive Vice President and |
|
|
|
|
Date: August 19, 2004 |
|
3
Exhibit Index
Exhibit |
| Description |
99.1 |
| Press Release, issued by Gilead Sciences, Inc. on August 17, 2004 |
4
